Bed nucleus of the stria terminalis-nucleus accumbens stimulation for depression: A randomized, double-blind, crossover trial

Although deep brain stimulation (DBS) shows potential in treatment-resistant depression (TRD), the efficacy remains controversial. To assess the efficacy of DBS of the bed nucleus of the stria terminalis (BNST) and nucleus accumbens (NAc) for TRD, we conduct a randomized, double-blind, crossover trial after an open-label optimization stage. Stimulation leads to a mean decrease in the Hamilton Depression Scale-17 (HAMD) scores of 10.1 points (p < 0.001) with a 50% response rate at the end of the open-label stage. Anxiety, quality of life, and disability are also improved. The HAMD scores are significantly lower in patients during active DBS than during sham DBS (p < 0.001). Serious adverse events include suicide (1 patient) and seizure (1 patients). With individual stimulation analysis, we identify optimal stimulation sites, fiber tracts, and functional networks (false discovery rate [FDR] p < 0.05). This study demonstrates the efficacy and safety of BNST-NAc DBS for TRD and reveals optimal brain targets for stimulation. This study was registered at ClinicalTrials.gov (NCT04530942).

Authors

Institutions

Publication Details

Journal
Cell Reports Medicine
Published
2026-03-31
DOI
https://doi.org/10.1016/j.xcrm.2026.102711
Primary Topic
Neurotransmitter Receptor Influence on Behavior
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bed nucleus of the stria terminalis-nucleus accumbens stimulation for depression: A randomized, double-blind, crossover trial

F. Wang, Kejia Hu, Linbin Wang, Ningfei Li et al.
Cell Reports Medicine
Neurotransmitter Receptor Influence on Behavior
article

Bed nucleus of the stria terminalis-nucleus accumbens stimulation for depression: A randomized, double-blind, crossover trial

F. Wang, Kejia Hu, Linbin Wang, Ningfei Li, Xian Qiu, Jinrong Zhang, Yijie Zhao, Zheng Ye, Qimin Liu, Xin Lv, Kuanghao Ye, Yijie Lai, Luling Dai, Yixin Pan, S. Zhan, Yingying Zhang, Yiru Fang, Valerie Voon, Ti-Fei Yuan, Wei Liu (20030), Chencheng Zhang, Xiaoxiao Zhang, Andres M. Lozano, Yuhan Wang, Peng Huang, Bomin Sun, Dianyou Li
article en

Abstract

Although deep brain stimulation (DBS) shows potential in treatment-resistant depression (TRD), the efficacy remains controversial. To assess the efficacy of DBS of the bed nucleus of the stria terminalis (BNST) and nucleus accumbens (NAc) for TRD, we conduct a randomized, double-blind, crossover trial after an open-label optimization stage. Stimulation leads to a mean decrease in the Hamilton Depression Scale-17 (HAMD) scores of 10.1 points (p < 0.001) with a 50% response rate at the end of the open-label stage. Anxiety, quality of life, and disability are also improved. The HAMD scores are significantly lower in patients during active DBS than during sham DBS (p < 0.001). Serious adverse events include suicide (1 patient) and seizure (1 patients). With individual stimulation analysis, we identify optimal stimulation sites, fiber tracts, and functional networks (false discovery rate [FDR] p < 0.05). This study demonstrates the efficacy and safety of BNST-NAc DBS for TRD and reveals optimal brain targets for stimulation. This study was registered at ClinicalTrials.gov (NCT04530942).

Cell Reports MedicineVol. 7(4)
Boston University (US), University Health Network (CA), Fudan University (CN), Toronto Rehabilitation Institute (CA), Ruijin Hospital (CN), Sir Run Run Shaw Hospital (CN), Shanghai Mental Health Center (CN), Humboldt-Universität zu Berlin (DE), Shanghai Institute for Science of Science (CN), Shanghai Center for Brain Science and Brain-Inspired Technology (CN), Krembil Research Institute, Zhejiang University (CN)
National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Shanghai Jiao Tong University, Medical Research Council, Fundamental Research Funds for the Central Universities, Scientific and Innovative Action Plan of Shanghai
Good health and well-being
Openalex Percentile: Top 35%
Neurotransmitter Receptor Influence on Behavior
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.